Simcere's Sanbexin® Sublingual Tablets Approved for Acute Ischemic Stroke Treatment Simcere Pharmaceutical's Sanbexin® sublingual tablets have received Chinese approval for treating acute ischemic stroke, promising significant improvements in recovery.

Simcere's Sanbexin® Sublingual Tablets Approved for Acute Ischemic Stroke Treatment #China #Nanjing #Simcere #Sanbexin #Stroke_Treatment